Home > Boards > US Listed > Biotechs > Assertio Therapeutics, INC (ASRT)

MM's manipulation

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
m1999 Member Profile
Member Level 
Followed By 792
Posts 56,491
Boards Moderated 27
Alias Born 03/10/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 5:16:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/1/2019 5:13:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2019 5:01:53 PM
Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors GlobeNewswire Inc. - 9/30/2019 12:35:20 PM
Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2019 6:36:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2019 4:14:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 8/20/2019 4:12:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2019 4:08:45 PM
Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire Inc. - 8/20/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 5:53:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2019 4:36:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 7:46:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2019 6:43:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2019 6:43:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:09:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 4:02:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 10:30:52 AM
Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021 GlobeNewswire Inc. - 8/9/2019 9:28:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:05:01 PM
Assertio Therapeutics Announces Strong Second-Quarter 2019 Results GlobeNewswire Inc. - 8/7/2019 4:02:00 PM
Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 201... GlobeNewswire Inc. - 7/17/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 5:21:43 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/10/2019 1:30:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/9/2019 6:28:42 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist